The global hydroxyapatite market was valued at US$ 480.2 million in 2022 and is likely to reach US$ 501.8 million by 2023. Furthermore, with rising demand from the healthcare industry, the overall sales of hydroxyapatite are expected to grow at a robust CAGR of 7.8% between 2023 and 2033, topping a valuation of US$ 1,063.5 million by 2033.
Hydroxyapatite is a naturally occurring mineral form of calcium apatite, generally used for bone repair and bone regeneration. It is being increasingly utilized in dental and orthopedic applications due to its optimum stability, biocompatibility, bioactivity, osteo-conductivity, and non-toxic nature.
Thermodynamically, hydroxyapatite is the most stable calcium phosphate compound under physical conditions such as temperature, pH, and composition of body fluids.
Due to the sheer growing preference for biomaterials, the dental implant and prosthetic industry are expected to have a direct impact on hydroxyapatite consumption. Over the forecast period, biochemical research is projected to propel the hydroxyapatite industry growth by expanding the application areas for 3-D printing and artificial bones.
| Attribute | Key Statistics |
|---|---|
| Hydroxyapatite Market Base Value (2022A) | US$ 480.2 million |
| Estimated Market Size (2023E) | US$ 501.8 million |
| Projected Market Size (2033F) | US$ 1,063.5 million |
| Value-based CAGR (2023 to 2033) | 7.8% |
| Collective Value Share: Top 3 Countries (2023E) | 53.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global hydroxyapatite market witnessed a CAGR of 4.1% during the historical period of 2018 to 2022. However, with the rising prevalence of medical conditions like periodontal bone defects and the growing usage of hydroxyapatite in treating these conditions, the overall hydroxyapatite industry is poised to grow at 7.8% CAGR between 2023 and 2033.
Hydroxyapatite is mostly used for bone repair and bone regeneration in the form of granules, blocks, and scaffolds, by itself or as a composite with polymers or other materials. Besides this, it finds application in biochemical research, surgical procedures, medicines, bioceramic coatings, etc.
Thus, the rapid expansion of medical & pharmaceuticals, cosmetics, food & other industries. worldwide is projected to eventually trigger the growth of the hydroxyapatite market during the forecast period.
Similarly, continuous technological advancements in various end-use industries and the consumption of hydroxyapatite in various technologies such as 3-D printing is expected to create sales prospects within the global hydroxyapatite industry over the forthcoming period.
Growing Demand for Implants Due to the Surge in Geriatric Population Pushing the Demand for Hydroxyapatite
In the elderly population, tooth loss has become a prevalent issue. According to the World Bank, the population over 65 has increased significantly during the past ten years. Various studies have revealed that the chances of developing ailments including osteoarthritis, knee, joint, and hip issues, as well as dental decay, are higher in the aging population.
There have also been escalating accidents worldwide that caused damage to bones, teeth, etc. The number of patients seeking such implants and replacements has increased significantly. As a result of this, there has been a rise in hydroxyapatite demand.
With an aging population and a surge in health issues across the world, demand for implants is expected to rise during the forecast period. This is projected to bolster the growth of the hydroxyapatite industry.
Rising Spending on Facial Rejuvenation Treatments to Create Opportunities for Hydroxyapatite Market
In the past ten years, non-surgical procedures for facial rejuvenation have become increasingly popular. There are numerous causes for this. Patients who want to see quick, natural results with the least amount of difficulty are drawn to these treatments since they are less expensive and need less recovery time than surgical procedures.
For these procedures, options including Botox and dermal fillers are available. As an alternative to collagen- and hyaluronic acid-based fillers, hydroxyapatite-based fillers are an excellent choice.
In terms of materials for wrinkle fillers, hydroxyapatite makes sense. Human teeth and bones naturally contain this harmless, biodegradable, and biocompatible mineral. The popular filler Radiesse, which is made of hydroxyapatite, is made up of tiny hydroxyapatite microspheres (particles) contained in a gel-like fluid. Moderate to facial folds, deep wrinkles, lipoatrophy, and similar issues are the most typical uses of hydroxyapatite-based cosmetic fillers.
Thus, increasing spending by consumers on facial rejuvenation treatments is expected to boost the growth of the hydroxyapatite industry during the forecast period.
Principal Consultant
Certain factors may hinder the market growth of the hydroxyapatite market during the forecast period. One of the key factors is the availability of alternatives such as titanium. Titanium and other metal-based implants currently dominate developing-country markets due to a lack of awareness and the fact that metallic implants are relatively cheaper.
Titanium implants have proven to be successful and compatible with body tissues. In the dental industry today, titanium is used in 95 percent of implants. The primary reason for this is that it is a strong, lightweight, non-toxic, and corrosion-resistant material.
Similarly, the high cost of hydroxyapatite implants is also likely to impact market growth during the forecast period.
Rising Healthcare Spending Boosting Hydroxyapatite Market Growth in the United States
| Country | The United States |
|---|---|
| Market Share % (2023) | 26.9% |
As per FMI’s latest analysis, the United States is projected to continue to dominate the North American hydroxyapatite market during the forecast period, owing to the better healthcare infrastructure, the surge in the number of non-invasive cosmetic surgeries, increasing healthcare spending, and strong presence of leading hydroxyapatite manufacturers.
The rapid rise in healthcare spending is a key factor driving growth in the United States hydroxyapatite market. According to the Centers for Medicare & Medicaid Services, the United States’ healthcare spending grew 9.7% in 2020, reaching US$ 4.1 trillion. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7%.
Similarly, as per World Bank data, the population over 65 in the United States accounted for approximately 16.6% of the total population, necessitating more medical attention for tooth decay and gum problems.
Thus, the growing adoption of highly advanced implants across the healthcare industry is expected to boost the demand for hydroxyapatite in the United States market during the assessment period. FMI predicts the United States hydroxyapatite industry to reach around US$ 266.2 million by the end of 2033.
Surge in Geriatric Population Driving Demand for Hydroxyapatite Across China
| Country | China |
|---|---|
| Market CAGR % (2023 to 2033) | 8.1% |
China is known as a manufacturing hub due to the large presence of manufacturing industries in the country. As per FMI, China is likely to remain the most dominant market for hydroxyapatite across East Asia during the forecast period.
Demand for hydroxyapatite in China is driven by a rapidly expanding healthcare industry, exploding aging population, rapid economic growth, a surge in the number of cosmetic surgeries, and expanded basic health insurance.
The aging population is one of the major concerns in China and it is expected to fuel the healthcare industry. The aging population necessitates more medical attention & treatment.
In China, the medical implants & orthopedics segment has a fair share in the medical devices market owing to the increasing adoption of surgeries to treat medical abnormalities. According to the International Trade Administration (ITA) dental, orthopedics & prosthetic segment accounted for a 12% share of China’s medical devices market for the year 2020.
In addition to this, as cited by ITA, China registered 264 million people aged 60 and above by the end of 2020, accounting for 18.7% of the total population. This demographic is expected to reach over 300 million by 2025.
The population of China is aging quickly and has a higher frequency of musculoskeletal conditions, especially osteoarthritis, and osteoporosis. The need for orthopedics products has increased as the coverage of basic health insurance has expanded. Hence, the scope of the hydroxyapatite industry in the Chinese market is expected to grow in the forecast period.
The hydroxyapatite industry in China is expected to expand at a CAGR of 8.1% during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Majority of Hydroxyapatite Sales Remain Concentrated in the Dental Industry
| Segment | Dental |
|---|---|
| Market Share % (2023) | 40.2% |
As per FMI, the dental segment is likely to provide lucrative growth opportunities for the hydroxyapatite manufacturers during the forecast period, owing to the rising usage in dental & orthopedic applications.
Hydroxyapatite is one of the building blocks that make tooth enamel, cementum & dentin. It helps in the remineralization of teeth and keeps teeth strong & healthy from enamel erosion & cavities. Hence it is actively being used in dental hygiene products or implants.
Nano-hydroxyapatite, which has crystals that range in size from 50 to 1000 nm, has exciting and soon-to-be-used applications in dentistry, thanks to the recently increasing interest in nanotechnology in numerous sectors.
When present in toothpaste, the nano-hydroxyapatite has a potent affinity for binding to proteins as well as to plaque and bacterial pieces. A study suggests that over 35% of people have untreated dental decay. Fluoride-free alternatives that contain hydroxyapatite have lately been proven to be effective as anti-caries agents.
69% of people between the ages of 35 and 44 have lost one or more permanent teeth due to trauma, gum disease, ineffective root canal therapy, or dental decay, according to data from the American Association of Oral and Maxillofacial Surgeons. Additionally, at the age of 74, 26% of people had lost every permanent tooth. It follows that there are between 100,000 and 300,000 dental implants used each year. From the abovementioned factors, the dental application is anticipated to reach about US$ 331.5 million by the end of 2033.
On the other hand, the orthopedics segment is anticipated to register a CAGR of 7.7% during the forecast period.
The hydroxyapatite industry is fairly consolidated with key players holding a significant share in the market. Key manufacturers are devoted to adopting strategies like investments in R&D, partnerships, collaborations, and acquisitions. They are also signing agreements & contracts with end-use industries for long-term supply of material & to gain more profit.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 501.8 million |
| Projected Market Valuation (2033) | US$ 1,063.5 million |
| Value-based CAGR (2023 to 2033) | 7.8% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value and Tons for Volume |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Germany, Italy, France, the United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, ANZ, GCC Countries, Northern Africa, South Africa |
| Key Segments Covered | Grade, Application, and Region |
| Key Companies Profiled | FLUIDINOVA; SofSera Corporation; Berkeley Advanced Biomaterials; Taihei Chemical Industrial Co. Ltd.; SigmaGraft; CAM Bioceramics; APS Materials, Inc.; Zimmer Biomet; Bioceramics; Granulab (M) Sdn Bhd; Merz Biomaterials; Sangi Co., Ltd. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The hydroxyapatite market is valued at US$ 501.8 million in 2023.
Some of the key hydroxyapatite market players are CeramTec, Implant Direct and Dentsply Sirona.
Nano-hydroxyapatite is likely to remain preferred through 2033.
The players opt for mergers and acquisitions.
India, Japan, and China dominate the Asian market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Grade
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Grade, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Grade, 2023 to 2033
5.3.1. Medical Grade
5.3.2. Cosmetics Grade
5.3.3. Research Grade
5.4. Y-o-Y Growth Trend Analysis By Grade, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Grade, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Dental
6.3.2. Orthopedic
6.3.3. Biochemical Research
6.3.4. Surgical
6.3.5. Bioceramic Coatings
6.3.6. Food
6.3.7. Medicine
6.3.8. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Grade
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Grade
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Grade
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Grade
9.3.3. By Application
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Grade
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Grade
10.3.3. By Application
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Grade
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Grade
11.3.3. By Application
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Grade
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Grade
12.3.3. By Application
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Grade
13.2.3. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Grade
13.3.3. By Application
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Grade
14.2.3. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Grade
14.3.3. By Application
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Grade
15.1.2.2. By Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Grade
15.2.2.2. By Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Grade
15.3.2.2. By Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Grade
15.4.2.2. By Application
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Grade
15.5.2.2. By Application
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Grade
15.6.2.2. By Application
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Grade
15.7.2.2. By Application
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Grade
15.8.2.2. By Application
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Grade
15.9.2.2. By Application
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Grade
15.10.2.2. By Application
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Grade
15.11.2.2. By Application
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Grade
15.12.2.2. By Application
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Grade
15.13.2.2. By Application
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Grade
15.14.2.2. By Application
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Grade
15.15.2.2. By Application
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Grade
15.16.2.2. By Application
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Grade
15.17.2.2. By Application
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Grade
15.18.2.2. By Application
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Grade
15.19.2.2. By Application
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Grade
15.20.2.2. By Application
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Grade
15.21.2.2. By Application
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Grade
15.22.2.2. By Application
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Grade
15.23.2.2. By Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Grade
16.3.3. By Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. FLUIDINOVA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. SofSera Corporation
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Berkeley Advanced Biomaterials
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Taihei Chemical Industrial Co. Ltd.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. SigmaGraft
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. CAM Bioceramics
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. APS Materials, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Zimmer Biomet
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Bioceramics
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Granulab (M) Sdn Bhd
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Merz Biomaterials
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Sangi Co., Ltd.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Hydroxyapatite Market
